Product Information
TOPIRAMATE ER 200 MG CAPSULE is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $20.3736 per EA under NDC 43598094230. Its NADAC has been published 32 times since Feb 25, 2026.
FDA first approved this application on Nov 17, 2023. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598094230
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA217231FDA Approved
11/17/2023
TE Code
AB1
On Market Since
2/1/2026
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE ER 200 MG CAPSULE has been published 32 times since Feb 25, 2026, and over the history we have for it it has declined 12.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.3736 per EA |
|---|---|
| All-time high | $23.7461 (Aug 12, 2026) |
| All-time low | $20.3736 (Sep 23, 2026) |
| 52-week high | $23.7461 |
| 52-week low | $20.3736 |
| Median price | $23.1283 |
| Average price | $22.7457 |
| Largest weekly change | -11.9% (Sep 23, 2026) |
| Weeks tracked | 32 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 53% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Topiramate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TOPIRAMATE ER 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 200 MG CAPSULE, manufactured by Dr. Reddy's Laboratories Inc., is $20.3736 per EA (NDC 43598094230), effective Sep 30, 2026.
How has the price of TOPIRAMATE ER 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE ER 200 MG CAPSULE has declined 12.0%. It has been tracked across 32 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 200 MG CAPSULE?
Since Feb 25, 2026, the NADAC for TOPIRAMATE ER 200 MG CAPSULE has ranged from a low of $20.3736 (Sep 23, 2026) to a high of $23.7461 (Aug 12, 2026), with a median of $23.1283 per EA.
Are there cheaper alternatives to TOPIRAMATE ER 200 MG CAPSULE?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE ER 200 MG SPRINK CAP, is $9.5420 per EA — about 53% below TOPIRAMATE ER 200 MG CAPSULE.
Who manufactures TOPIRAMATE ER 200 MG CAPSULE?
TOPIRAMATE ER 200 MG CAPSULE (NDC 43598094230) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.